Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research
REDWOOD CITY, Calif., Oct. 19 /PRNewswire/ — IngenuityÂ® Systems, the leading provider of information solutions for life science researchers, and TransMed Systems, a translational medicine software and services company, today announced an integration between IPAÂ® software and XB Bio-Integration Suite (XB-BIS). Researchers can now easily take pre-clinical and clinical data that is managed and statistically analyzed by XB-BIS, directly into IPAÂ®, which is used by researchers to model, analyze, and explore various types of ‘omics data to gain a deeper understanding of complex biological systems.
The software integration supports academic and commercial researchers who are studying how genes affect the way individuals respond to drug treatments. Joint customers will have a clear workflow to analyze pre-clinical and clinical data in the context of signaling and metabolic pathways, networks, and cellular processes available in IPA. This approach helps researchers move rapidly and confidently from hypothesis generation to validation experiments.
Nick Berens, CEO, TransMed Systems, said, “The integration between XB-BIS and IPA will enable physicians, clinicians and researchers to integrate the latest biological content, pathways and molecular networks into their translational medicine and research. These enhanced capabilities will allow for more timely and informed treatment strategies and practices and improve personalized medicine.”
Doug Bassett, Ph.D., CSO and CTO, Ingenuity Systems, stated, “Personalized medicine requires the ability to quickly translate large amounts of data into meaningful biological information. We’re very pleased that our partnership with TransMed will provide a streamlined platform from which researchers and clinicians will be able to collect and analyze data, link genotypes to phenotypes, identify potential biomarkers, generate powerful and informed hypotheses, and understand the molecular differences between patient populations for improved diagnostics and therapeutics.”
About IngenuityÂ® Systems
Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. For more information visit: www.ingenuity.com
About TransMed Systems
TransMed Systems, was founded as a next generation life science application and services company with headquarters in Cupertino, California. The focus of TransMed Systems is to provide leading edge software and service solutions expediting the complete life science work process from novel discovery to clinical application in an integrated environment. TransMed Systems markets its XB Bio-Integration Suite as a fully integrated biological and medical informatics solution that allows users to generate, refine, and validate causal hypotheses across disparate data sets. The purpose is to provide a complete solution in the area of translational biomedical research, whereby bench-side research can rapidly lead to discoveries that can be readily applied to bedside medicine. http://www.xbtransmed.com/
SOURCE Ingenuity Systems